Does anti-major histocompatibility complex class II treatment prevent graft rejection in the hamster-to-rat cardiac xenograft?
The mechanism of action of this combination is complex and could be caused by an initial inhibition of B cell function by the anti-MHC class II treatment and the subsequent inhibition of T cell dependent pathways by CyA.
Gallstones increase the risk of colonic adenoma. No association exists with cholecystectomy.